UZ Gent | D.R.U.G. | Health, innovation and research institute | Princess Elisabeth Children’s Hospital

Meeting venue

Scientific program

Thursday 25 April 2024

12.00 | Registration with light lunch
13.00 | Welcome | Prof. Dr Piet Hoebeke, Dean of the Faculty of Medicine and Health Sciences, Ghent University
13.15 | New directions/new mode of actions studied in phase I trials | Dr Rachel Galot, Cliniques Universitaires Saint-Luc
13.45 | Statistical interpretation of clinical trial data | Dr Alexander Decruyenaere, Ghent University Hospital
14.15 | Challenges in development of CAR-T therapies in pediatrics | Prof. Dr Claudia Rössig, University Hospital Münster
14.45 | Melanoma: more progress, more hope, more time | Dr Celine Jacobs, Ghent University Hospital
15.15 | Tea break & visit exhibitors
15.45 | Challenges in performing clinical trials in low incidence disease | Prof. Dr Sylvie Rottey and Dr Levi Hoste, Ghent University Hospital
16.15 | Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM | Prof. Dr Ina Oehme, DKFZ Heidelberg
16.45 | Closing word | Philippe Van Rompaey, Ghent University Hospital
17.15 | Networking drink

Friday 26 April 2024

08.30 | Registration with coffee
09.00 | Welcome | Prof. Dr Frank Vermassen, Chief Physician Ghent University Hospital
09.15 | Clinical Trials in Rare Diseases | Dr Eva Degraeuwe, Ghent University / Ghent University Hospital
09.45 | CHIM story – human challenge trials | Prof. Pierre Van Damme, University of Antwerp
10.15 | First learnings from the European clinical trial regulation and its impact on research in Belgium | Tim Weglewski, IQVIA
10.45 | Coffee break & visit exhibitors
11.30 | Gene therapies in ophthalmology | Prof. Dr Bart Leroy, Ghent University Hospital
12.00 | Patients as partners: the power of a Patient Advisory Board for clinical research (PAWO) | Wendy Van de Velde, Ghent University Hospital
12.30 | Networking lunch & visit exhibitors
13.30 | Leveraging RCTs to unravel fundamental biology: lessons from COVID-19 | Dr Karel Van Damme, Ghent University / IRC
14.00 | Future GMP facility for Gene and Cell therapy at U(Z) Gent | Dr Tim Desmet, Ghent University
14.30 | Sarcoma models database/website | Prof. Dr Olivier De Wever, Ghent University
15.00 | Cochrane reviews: content – method – purpose. Post marketing surveillance | Dr Ellen Van Leeuwen, Ghent University
15.30 | Closing word | Prof. Dr Sylvie Rottey, Ghent University Hospital
16.00 | Farewell reception

RIZIV / INAMI accreditation will be requested.

Registration

Advance registration and payment is required by 18 April 2024

Upon successful registration, all registered participants will receive a confirmation of registration by email.
Please check your spam folder in case you do not receive it.

The organizers acknowledge the support of the following sponsors:

Gold sponsor

Bristol-Myers Squibb Belgium SA

Bronze sponsors

Roche NV / SA
Astellas Pharma BV
MSD Belgium